NDAORALPOWDERPriority Review
Approved
Dec 1982
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Priority Review
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CALCIBIND is an oral powder formulation of cellulose sodium phosphate, a non-absorbed resin used to reduce urinary calcium excretion in patients with hypercalciuria and kidney stone disease. The drug binds dietary calcium in the gastrointestinal tract, thereby decreasing the amount of calcium available for urinary excretion. It represents an older, established therapeutic approach to stone prevention in select patient populations.
LOE Approaching
Declining revenue cycle with modest competitive pressure (30%) suggests lean team structure and limited growth opportunities for new hires.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CALCIBIND offers limited growth trajectory and minimal active job openings, reflecting the product's late-stage lifecycle and narrow therapeutic niche. Roles are primarily defensive, focused on maintaining prescriber relationships and navigating reimbursement rather than launching or expanding the franchise.
Regulatory AffairsMedical Science Liaison
Worked on CALCIBIND at Mission Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.